Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001225208-16-037707)

Filing Details

Accession Number:: 0001225208-16-037707
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2016-08-10 16:57:10
Reporting Period:: 2016-08-10

Filing Date:: 2016-08-10
Accepted Time:: 2016-08-10 16:57:10
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
310158	Merck & Co. Inc.	MRK	Pharmaceutical Preparations (2834)	221918501

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1563786	Clark Golestani	Merck &Amp; Co., Inc. 2000 Galloping Hill Road Kenilworth NJ 07033	Evp & Chief Info Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2016-08-10	3,000	$63.03	14,083	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock - 401(K) Plan	5,860	Indirect	By 401(k)

Footnotes

Holdings include shares acquired in dividend reinvestment transactions.
Holdings include shares acquired and dividends earned through July 8, 2016, in the Merck U.S. Savings Plan, a 401(k) plan. In addition, since the date of the reporting person's last ownership report, shares of Merck & Co., Inc. common stock within the 401(k) plan were disposed pursuant to a domestic relations order.